Ramakrishna Nirogi

2.6k total citations
198 papers, 2.1k citations indexed

About

Ramakrishna Nirogi is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ramakrishna Nirogi has authored 198 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pharmacology, 63 papers in Molecular Biology and 37 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ramakrishna Nirogi's work include Receptor Mechanisms and Signaling (35 papers), Cholinesterase and Neurodegenerative Diseases (33 papers) and Analytical Methods in Pharmaceuticals (32 papers). Ramakrishna Nirogi is often cited by papers focused on Receptor Mechanisms and Signaling (35 papers), Cholinesterase and Neurodegenerative Diseases (33 papers) and Analytical Methods in Pharmaceuticals (32 papers). Ramakrishna Nirogi collaborates with scholars based in India, United States and United Kingdom. Ramakrishna Nirogi's co-authors include Vishwottam Kandikere, Koteshwara Mudigonda, Gopinadh Bhyrapuneni, S. Maurya, Manoj K. Shukla, Pradeep Jayarajan, Prashanth Komarneni, Vijay Benade, Anil Shinde and Renny Abraham and has published in prestigious journals such as Neurology, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Ramakrishna Nirogi

190 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ramakrishna Nirogi

Since Specialization

Citations

This map shows the geographic impact of Ramakrishna Nirogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramakrishna Nirogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramakrishna Nirogi more than expected).

Fields of papers citing papers by Ramakrishna Nirogi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramakrishna Nirogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramakrishna Nirogi. The network helps show where Ramakrishna Nirogi may publish in the future.

Co-authorship network of co-authors of Ramakrishna Nirogi

This figure shows the co-authorship network connecting the top 25 collaborators of Ramakrishna Nirogi. A scholar is included among the top collaborators of Ramakrishna Nirogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramakrishna Nirogi. Ramakrishna Nirogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resveratrol, a calorie restriction mimetic, protects AlCl3-induced neurotoxicity and cognitive deficits in rats via inhibition of oxidative stress 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Vijay Benade, Pradeep Jayarajan, Krishnadas Nandakumar, Ramakrishna Nirogi	0
2	SUVN‐L3307032, A Positive Allosteric Modulator (PAM) at Muscarinic M4 Receptor for the Treatment of Neuropsychiatric Symptoms 2024 ·Alzheimer s & Dementia ·Anil Shinde, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Radhey Shyam, (unknown), Renny Abraham, Ramakrishna Nirogi	1
3	Samelisant (SUVN-G3031) - Topline Results from the Phase-2 Proof-of-Concept Double-blind, Placebo-controlled Study in Patients with Narcolepsy (P10-9.002) 2024 ·Neurology ·Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, Vinod Goyal, Anil Shinde, (unknown), (unknown), (unknown)	1
4	0051 Samelisant, a H3 Receptor Inverse Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease 2023 ·SLEEP ·Ramakrishna Nirogi, Vijay Benade, Renny Abraham, (unknown), (unknown), (unknown), (unknown), (unknown), Ramkumar Subramanian	1
5	Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders 2023 ·Biomolecules ·Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, (unknown), (unknown), Vijay Benade, Vinod Goyal, Renny Abraham, (unknown), Jeffrey L. Cummings	31
6	0609 Samelisant, Histamine 3 Receptor Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy 2023 ·SLEEP ·Ramakrishna Nirogi, (unknown), Pradeep Jayarajan, Vinod Goyal, (unknown), Anil Shinde, Vijay Benade	3
7	Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations 2023 ·Journal of Pharmaceutical Sciences ·(unknown), Ramakrishna Nirogi, Manthan D Janodia	1
8	Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling 2023 ·European Journal of Pharmacology ·Ramakrishna Nirogi, (unknown), (unknown), (unknown), Renny Abraham, (unknown), Veera Raghava Chowdary Palacharla, (unknown), (unknown), Ramkumar Subramanian, (unknown), (unknown), Vijay Benade, Pradeep Jayarajan, (unknown)	3
9	Potential benefits of Masupirdine (SUVN-502) on Behavioral and Psychological symptoms in patients with moderate Alzheimer’s Disease (5090) 2020 ·Neurology ·Ramakrishna Nirogi, Anil Shinde, Pradeep Jayarajan, Vinod Goyal, (unknown), Ramkumar Subramanian, (unknown), (unknown), (unknown)	3
10	Mechanistic evaluation of tapentadol in reducing the pain perception using in-vivo brain and spinal cord microdialysis in rats 2017 ·European Journal of Pharmacology ·Vijay Benade, Ramakrishna Nirogi, Gopinadh Bhyrapuneni, (unknown), (unknown), (unknown), (unknown), (unknown)	10
11	Simultaneous monitoring of electroencephalographic characteristics in animals subjected to behavioral tests: a preclinical investigation 2017 ·Behavioural Pharmacology ·Ramakrishna Nirogi, (unknown), Vijay Benade, (unknown), Gopinadh Bhyrapuneni, Pradeep Jayarajan	4
12	Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats 2012 ·European Journal of Drug Metabolism and Pharmacokinetics ·Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Vishwottam Kandikere, Vijay Benade, Nageswararao Muddana, Ramanatha Saralaya, (unknown), (unknown), K. Mukkanti	16
13	Synthesis of novel (1-substituted benzenesulfonyl-1H-indol-5-yl)-(4-substituted piperazin-1-yl)-methanone derivatives as 5-HT6R ligands 2011 ·Der pharma chemica ·Ramakrishna Nirogi, (unknown), Anil Shinde, (unknown), (unknown), P. K. Dubey	0
14	Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain 2011 ·European Journal of Pharmacology ·Ramakrishna Nirogi, Pradeep Jayarajan, Renny Abraham, (unknown), Mohammed Abdul Rasheed, (unknown), (unknown)	22
15	Chromatography–mass spectrometry methods for the quantitation of statins in biological samples 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Ramakrishna Nirogi, Koteshwara Mudigonda, Vishwottam Kandikere	73
16	CHIRAL HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR ENANTIOSELECTIVE ANALYSIS OF ZALTOPROFEN 2006 ·Acta Chromatographica ·Ramakrishna Nirogi, (unknown), (unknown), Vishwottam Kandikere, Koteshwara Mudigonda	6
17	Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma 2006 ·Biomedical Chromatography ·Ramakrishna Nirogi, Vishwottam Kandikere, Koteshwara Mudigonda, Manoj K. Shukla, S. Maurya	29
18	Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry 2006 ·Analytical and Bioanalytical Chemistry ·Ramakrishna Nirogi, Vishwottam Kandikere, Manoj K. Shukla, Koteshwara Mudigonda, (unknown), (unknown), Yerramilli Anjaneyulu	16
19	Quantification of clopidogrel in human plasma by sensitive liquid chromatography/tandem mass spectrometry 2006 ·Rapid Communications in Mass Spectrometry ·Ramakrishna Nirogi, Vishwottam Kandikere, Manoj K. Shukla, Koteshwara Mudigonda, S. Maurya, (unknown)	44
20	Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of fluvastatin in human plasma: validation and its application to pharmacokinetic studies 2006 ·Rapid Communications in Mass Spectrometry ·Ramakrishna Nirogi, Vishwottam Kandikere, (unknown), Koteshwara Mudigonda, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact